Skip to content

Prescribing Appropriateness of Thrombo-prophylaxis in Intensive Care Unit of Tertiary Hospital

Pattern of Prescribing Anticoagulants As DVT Prophylaxis in Intensive Care Unit of Tertiary Hospital

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06539156
Enrollment
400
Registered
2024-08-06
Start date
2024-08-01
Completion date
2024-12-01
Last updated
2024-12-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

DVT

Brief summary

Hospitalized patients are at high risk of venous thromboembolism (VTE), and the appropriate use of thromboprophylaxis can significantly reduce the incidence of VTE in high-risk patients. We investigated the pattern of VTE prophylaxis administration among elderly medical patients and assessed its appropriateness based on the American College of Chest Physicians (ACCP) recommendations. Methods A cross-sectional single-center study will be conducted between July 2024 and December 2024, including hospitalized (\> 48 h), (≥ 60 years), medical and surgical patients, and excluding patients receiving anticoagulant for other reason, having contraindication to thromboprophylaxis, or had VTE diagnosed within 48 h. The Padua and caprine prediction scores will be used to determine the patients' risk for VTE, and thromboprophylaxis use will be assessed against the ACCP recommendations.

Interventions

OTHERDVT prophyllaxis

VTE prophylaxis administration among patients based on the American College of Chest Physicians (ACCP) recommendations

Sponsors

Egyptian Chinese University
CollaboratorOTHER
Teachers Hospital
CollaboratorUNKNOWN
Ain Shams University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patient records * admitted to the ICU with * medical or surgical causes * recieved anticoagulants for DVT prophylaxis

Exclusion criteria

* Patients already on anticoagulant therapy, * had history of previous DVT, * had End-stage liver disease, * admitted with hemorrhage/bleeding * not prescribed DVT prophylaxis

Design outcomes

Primary

MeasureTime frameDescription
Padua score for medical patientswithin 24 hours of ICU admissionVenous thromboembolism Risk assessment (Scores 0-3 are low risk and do not warrant prophylaxis. Scores ≥4 are high risk for VTE and subsequent complications; recommendation for thromboprophylaxis.)
Caprini score for surgical patientswithin 24 hours of ICU admissionVenous thromboembolism Risk assessment (Total score of 0-1: Low risk of VTE Total score of ≥3: High/moderate risk of VTE )

Secondary

MeasureTime frameDescription
Bleeding risk assessmentwithin 24 hours of ICU admission
Direct Anticoagulant costwithin 24 hours of ICU admission till ICU discharge(at least 48 hours)sum of costs related to the anticoagulant administration for DVT Prophylaxis
Adverse drug reaction costwithin 24 hours of ICU admission till ICU discharge (at least 48 hours)sum of costs related to the Adverse drug reaction for DVT Prophylaxis

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 5, 2026